Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Financial issues in defining levels for HIV/AIDS research

S R Eastaugh1

  • 1Department of Health Policy and Management, School of Public Health and Health Services, George Washington University, Washington, DC, USA.

Journal of Health Care Finance
|August 27, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hospital costs and specialization: benefits of trimming product lines.

Journal of health care finance·2001
Same author

National healthcare spending and fiscal control: comparisons among 15 countries.

Hospital topics·2001
Same author

Cost-effective potential for home health care.

Managed care quarterly·2001
Same author

New ventures require accurate risk analyses and adjustments.

Healthcare financial management : journal of the Healthcare Financial Management Association·2000
Same author

Willingness to pay in treatment of bleeding disorders.

International journal of technology assessment in health care·2000
Same author

Managing risk in a risky world.

Journal of health care finance·1999
Same journal

The Growing Importance of Cost Accounting for Hospitals.

Journal of health care finance·2019
Same journal

Cost of Practice Transformation in Primary Care: Joining an Accountable Care Organization.

Journal of health care finance·2019
Same journal

Assessing the cost burden of United States FDA-mandated post-approval studies for medical devices.

Journal of health care finance·2017
Same journal

Determinants of differentials in pneumonia mortality in the UK and France.

Journal of health care finance·2014
Same journal

Health policies and intervention strategies: a description of current issues and approaches to care of the public health and health care system in the United Arab emirates.

Journal of health care finance·2014
Same journal

The impact of star physicians on diffusion of a medical technology: the case of laparoscopic gastric bypass surgery.

Journal of health care finance·2014
See all related articles

Accurate cost identification is crucial for fair payment in acquired immune deficiency syndrome (AIDS) research. Activity-based costing can reveal inefficient care patterns and inform stable funding mechanisms for biomedical innovation.

Area of Science:

  • Health Economics
  • Biomedical Research Funding
  • Public Health Policy

Background:

  • Acquired immune deficiency syndrome (AIDS) research requires substantial funding.
  • Current cost identification methods may not accurately reflect the true expenses involved in AIDS research and care.
  • Fair payment systems are essential for sustaining research and innovation.

Purpose of the Study:

  • To outline the challenges in cost identification for AIDS research.
  • To explore the complexities of establishing fair payment mechanisms for research and care.
  • To advocate for improved cost-finding and payment strategies to support biomedical innovation.

Main Methods:

  • Analysis of cost identification issues in AIDS research.
  • Discussion of activity-based costing as a method for understanding care patterns.

Related Experiment Videos

  • Examination of payer perspectives on cost identification and payment.

    • Main Results:

    • Overutilization of hospitals and underutilization of prevention/education contribute to expensive care patterns.
    • Activity-based costing can illuminate structural inefficiencies in care delivery.
    • Managers require better understanding of cost identification challenges faced by payers.

    Conclusions:

    • A stable, fair funding mechanism is needed for AIDS research and innovation.
    • Collaboration among healthcare professionals is vital for defining sustainable funding.
    • Fair payment for indirect costs is a necessary component of research support, not an arbitrary profit.